Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Feb 1, 2026 9:00 AM ・ Updated Jun 15, 2026 12:22 AM ・ 2 min read ・ Source: PR Times
Wuding (1733) announced its February 2026 monthly revenue was NT$178 million, a 12.0% decrease compared to the same period last year. As a leading biotech and medical industry player specializing in blood glucose monitoring systems, its revenue performance is related to changes in demand in the global diabetes care market.
Company Code: 1733 Company Name: Wuding Industry: Biotechnology and Medical Industry Data Month/Year: 2026-02 Current Month Revenue: NT$178,279 Thousand (NT$178 Million) Year-over-year Change from Same Month Last Year: -12.0%
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.